Dr. Doug McNair assists the foundation’s disease-focused programs with biostatistics and quantitative trial design and simulation.
Doug is the lead inventor on more than 200 patents and pending patent applications, including several involving Bayesian predictive models for clinical diagnostics.
Before joining the foundation in 2019, Doug was president of the predictive math modeling and artificial intelligence (AI) division at Cerner Corporation (later acquired by Oracle), where he led a team of statisticians, data scientists, and applied mathematicians engaged in health services research, pharmacovigilance, and discovering AI predictive models from real-world deidentified big data derived from electronic health records.
Earlier, he held several executive roles at pharmaceutical and medical device firms, including senior vice president of R&D, vice president of clinical development, and vice president of regulatory affairs.
Doug is a medical doctor and has a Ph.D. in Biomedical Engineering and Biostatistics.
More about the foundation
Learn about where we work around the globe and the programs we've created to address urgent issues in global health, global development, and education.
Read the latest stories, research, and news from across the foundation and subscribe to our weekly newsletter, The Optimist.